BR

Healthcare · Pharmaceuticals

Brooks Laboratories Ltd (BROOKS)

₹67.20

Mkt cap
₹200 Cr
P/E ratio
69.10
P/B
1.03
Div yield
0.00%
ROE
4.68%
ROCE
5.04%
EPS (TTM)
₹0.97
Book value
₹65
52W range
36–109
Sector
Healthcare

Price history

Previous close

Incorporated in 2002, Brooks Laboratories Ltd is a pharmaceutical company working on contract basis catering to the critical care segment [1]

NSE BROOKSBSE 533543
Health check
Cautious
ValuationExpensive
ProfitabilityWeak
GrowthLow
TechnicalsNeutral
52-week range
−38.18% from high
₹67
₹36+85.12% from low₹109
Current
₹67.20
Prev close
₹67.30
Day
−0.15%
Price performance
1D
−0.39%
1W
+4.72%
1M
+9.74%
3M
+11.18%
6M
+30.99%
1Y
−37.32%
YTD
−13.02%

Financials

Revenue, profit & margin
P/E ratio
69.1×
BROOKS is 107% above the sector median of 33.4×
BROOKS69.1×
Sector median33.4×
 Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026NSETrend
Sales15.7024.3221.7517.7217.9320.7920.5223.3225.5123.4516.5720.2122.9619
YoY Sales growth-8.29%+34.51%+42.16%+40.52%+14.20%-14.51%-5.66%+31.60%+42.28%+12.79%-19.25%-13.34%-10.00%—
Expenses19.6125.4225.1227.2519.8524.2022.0224.5822.3820.9315.8419.5324.3019
Operating Profit-3.91-1.10-3.37-9.53-1.92-3.41-1.50-1.263.132.520.730.68-1.340
OPM %-24.90%-4.52%-15.49%-53.78%-10.71%-16.40%-7.31%-5.40%12.27%10.75%4.41%3.36%-5.84%2%
Other Income0.050.090.160.650.070.200.030.627.156.135.321.350.1873
Interest0.170.190.210.270.160.320.280.260.300.280.160.090.210
Depreciation0.440.440.430.460.400.430.380.390.390.390.390.410.420
Profit before tax-4.47-1.64-3.85-9.61-2.41-3.96-2.13-1.299.597.985.501.53-1.7973
Tax %0.00%0.00%0.78%0.00%0.00%0.00%0.00%13.95%0.00%0.00%0.00%0.00%0.00%7%
Net Profit-4.47-1.64-3.88-9.61-2.41-3.96-2.13-1.469.587.985.501.52-1.7968
EPS in Rs-1.80-0.62-1.48-3.66-0.92-1.51-0.81-0.503.252.711.870.52-0.6122.95
Raw PDF—

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −0.46% · closed higher next day 1 of last 2
 Q1FY27Q2FY27
Broadcast13 Aug '26◦7 Nov '26◦
Earnings day−4.86%+3.95%
+1 day−7.53%+6.15%
+5 days−8.54%+7.19%
+15 days+0.72%—
+30 days−13.80%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
52.62%Promoter
Promoters52.62%
FIIs0.04%0.04
DIIs10.50%0.12
Public36.84%0.16
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,870.0036.464,48,6760.86%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,150.0086.622,95,9970.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,668.8081.801,77,5860.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,338.0094.281,26,3250.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,204.2026.511,20,1190.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,388.0041.411,15,9360.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,388.0036.111,12,1350.94%852−35.05%7,404−2.44%15.49%
Brooks Lab.₹67.8069.112000.00%70−75.00%19−17.91%5.04%
Median: 160 Co.₹445.7333.352,0160.08%13+33.73%179+21.23%14.94%

Filings